dc.contributor.author | Sevindik, Ömür Gökmen | |
dc.contributor.author | Özkurt, Zübeyde Nur | |
dc.contributor.author | Boğa, Can | |
dc.contributor.author | Kalayoğlu Beşışık, Sevgi | |
dc.contributor.author | Yıldız, İpek | |
dc.contributor.author | Gedük, Ayfer | |
dc.contributor.author | Harmandali, Aybüke | |
dc.contributor.author | Salihoğlu, Ayşe | |
dc.contributor.author | Haydaroğlu Şahin, Handan | |
dc.contributor.author | Sönmez, Mehmet | |
dc.contributor.author | Vural, Filiz | |
dc.contributor.author | Akay, Olga Meltem | |
dc.contributor.author | Kurt Yüksel, Meltem | |
dc.contributor.author | Maral, Senem | |
dc.contributor.author | Ekinci, Ömer | |
dc.contributor.author | Kırkızlar, Hakkı Onur | |
dc.contributor.author | Tekinalp, Atakan | |
dc.contributor.author | Demir, Nazlı | |
dc.contributor.author | Merter, Mustafa | |
dc.contributor.author | Saydam, Güray | |
dc.contributor.author | Alacacıoğlu, İnci | |
dc.contributor.author | Yeğin, Zeynep Arzu | |
dc.contributor.author | Kaşar, Mutlu | |
dc.contributor.author | Mastanzade, Metban | |
dc.contributor.author | Özsan, Güner Hayri | |
dc.date.accessioned | 2022-09-19T07:23:37Z | |
dc.date.available | 2022-09-19T07:23:37Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.citation | Sevindik, Ö. G., Özkurt, Z. N., Boğa, C., Kalayoğlu Beşışık, S., Yıldız, İ., Gedük, A. ... Özsan, G. H. (2021). An interim analysis of the Turkish myeloma registry among the patients who have received up to two lines of therapy. Blood. https://dx.doi.org/10.1182/blood-2021-150175 | en_US |
dc.identifier.issn | 0006-4971 | |
dc.identifier.issn | 1528-0020 | |
dc.identifier.uri | https://dx.doi.org/10.1182/blood-2021-150175 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/9729 | |
dc.description.abstract | ... | en_US |
dc.language.iso | eng | en_US |
dc.publisher | American Society of Hematology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Analysis | en_US |
dc.subject | Myeloma | en_US |
dc.subject | An Interim Analysis | en_US |
dc.title | An interim analysis of the Turkish myeloma registry among the patients who have received up to two lines of therapy | en_US |
dc.type | conferenceObject | en_US |
dc.relation.ispartof | Blood | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0001-9636-4113 | en_US |
dc.identifier.volume | 138 | en_US |
dc.identifier.issue | Supplement: 1 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1182/blood-2021-150175 | en_US |
dc.institutionauthor | Sevindik, Ömür Gökmen | |
dc.identifier.wosquality | Q1 | en_US |
dc.identifier.wos | 000835740102199 | en_US |